Logo image of BKD

BROOKDALE SENIOR LIVING INC (BKD) Stock Fundamental Analysis

NYSE:BKD - New York Stock Exchange, Inc. - US1124631045 - Common Stock - Currency: USD

6.37  +0.07 (+1.11%)

After market: 6.3 -0.07 (-1.1%)

Fundamental Rating

1

Taking everything into account, BKD scores 1 out of 10 in our fundamental rating. BKD was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of BKD have multiple concerns. BKD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BKD had negative earnings in the past year.
BKD had a positive operating cash flow in the past year.
In the past 5 years BKD reported 4 times negative net income.
Of the past 5 years BKD 4 years had a positive operating cash flow.
BKD Yearly Net Income VS EBIT VS OCF VS FCFBKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

BKD has a Return On Assets of -3.19%. This is in the lower half of the industry: BKD underperforms 61.76% of its industry peers.
Looking at the Return On Equity, with a value of -95.04%, BKD is doing worse than 76.47% of the companies in the same industry.
BKD has a worse Return On Invested Capital (0.76%) than 60.78% of its industry peers.
Industry RankSector Rank
ROA -3.19%
ROE -95.04%
ROIC 0.76%
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
BKD Yearly ROA, ROE, ROICBKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Operating Margin of BKD (1.76%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BKD has grown nicely.
BKD has a Gross Margin of 25.57%. This is comparable to the rest of the industry: BKD outperforms 50.98% of its industry peers.
BKD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.76%
PM (TTM) N/A
GM 25.57%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
BKD Yearly Profit, Operating, Gross MarginsBKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BKD is destroying value.
The number of shares outstanding for BKD has been increased compared to 1 year ago.
Compared to 5 years ago, BKD has more shares outstanding
BKD has a better debt/assets ratio than last year.
BKD Yearly Shares OutstandingBKD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BKD Yearly Total Debt VS Total AssetsBKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

BKD has an Altman-Z score of -0.26. This is a bad value and indicates that BKD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.26, BKD is doing worse than 80.39% of the companies in the same industry.
A Debt/Equity ratio of 20.19 is on the high side and indicates that BKD has dependencies on debt financing.
The Debt to Equity ratio of BKD (20.19) is worse than 85.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 20.19
Debt/FCF N/A
Altman-Z -0.26
ROIC/WACC0.1
WACC7.33%
BKD Yearly LT Debt VS Equity VS FCFBKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 0.88 indicates that BKD may have some problems paying its short term obligations.
BKD has a Current ratio of 0.88. This is in the lower half of the industry: BKD underperforms 78.43% of its industry peers.
BKD has a Quick Ratio of 0.88. This is a bad value and indicates that BKD is not financially healthy enough and could expect problems in meeting its short term obligations.
BKD has a worse Quick ratio (0.88) than 71.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
BKD Yearly Current Assets VS Current LiabilitesBKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BKD have decreased by -5.95% in the last year.
The Revenue has been growing slightly by 3.63% in the past year.
Measured over the past years, BKD shows a decrease in Revenue. The Revenue has been decreasing by -5.08% on average per year.
EPS 1Y (TTM)-5.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.5%
Revenue 1Y (TTM)3.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.51%

3.2 Future

BKD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.66% yearly.
Based on estimates for the next years, BKD will show a small growth in Revenue. The Revenue will grow by 1.53% on average per year.
EPS Next Y36.45%
EPS Next 2Y21.46%
EPS Next 3Y18.66%
EPS Next 5YN/A
Revenue Next Year2.69%
Revenue Next 2Y-0.51%
Revenue Next 3Y1.53%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BKD Yearly Revenue VS EstimatesBKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
BKD Yearly EPS VS EstimatesBKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BKD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BKD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKD Price Earnings VS Forward Price EarningsBKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BKD is valued a bit cheaper than the industry average as 60.78% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.53
BKD Per share dataBKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

BKD's earnings are expected to grow with 18.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.46%
EPS Next 3Y18.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BKD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BROOKDALE SENIOR LIVING INC

NYSE:BKD (4/28/2025, 8:04:00 PM)

After market: 6.3 -0.07 (-1.1%)

6.37

+0.07 (+1.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)05-06 2025-05-06
Inst Owners106.89%
Inst Owner Change0.03%
Ins Owners3.68%
Ins Owner Change-0.83%
Market Cap1.28B
Analysts73.33
Price Target7.14 (12.09%)
Short Float %3.91%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.06%
Min EPS beat(2)-74.45%
Max EPS beat(2)-25.67%
EPS beat(4)1
Avg EPS beat(4)-21.47%
Min EPS beat(4)-74.45%
Max EPS beat(4)26.45%
EPS beat(8)3
Avg EPS beat(8)-5.89%
EPS beat(12)4
Avg EPS beat(12)-2.98%
EPS beat(16)7
Avg EPS beat(16)16.88%
Revenue beat(2)0
Avg Revenue beat(2)-1.05%
Min Revenue beat(2)-1.1%
Max Revenue beat(2)-1%
Revenue beat(4)0
Avg Revenue beat(4)-1.09%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-0.88%
Revenue beat(12)0
Avg Revenue beat(12)-0.72%
Revenue beat(16)0
Avg Revenue beat(16)-1.27%
PT rev (1m)1.45%
PT rev (3m)1.45%
EPS NQ rev (1m)3.15%
EPS NQ rev (3m)24.67%
EPS NY rev (1m)3.45%
EPS NY rev (3m)11.58%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-1.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.41
P/FCF N/A
P/OCF 7.67
P/B 6
P/tB 6.89
EV/EBITDA 12.53
EPS(TTM)-0.89
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)0.83
OCFY13.03%
SpS15.61
BVpS1.06
TBVpS0.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.19%
ROE -95.04%
ROCE 0.96%
ROIC 0.76%
ROICexc 0.8%
ROICexgc 0.81%
OM 1.76%
PM (TTM) N/A
GM 25.57%
FCFM N/A
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 20.19
Debt/FCF N/A
Debt/EBITDA 10.15
Cap/Depr 84.26%
Cap/Sales 9.91%
Interest Coverage 0.23
Cash Conversion 39.32%
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z -0.26
F-Score6
WACC7.33%
ROIC/WACC0.1
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.5%
EPS Next Y36.45%
EPS Next 2Y21.46%
EPS Next 3Y18.66%
EPS Next 5YN/A
Revenue 1Y (TTM)3.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.51%
Revenue Next Year2.69%
Revenue Next 2Y-0.51%
Revenue Next 3Y1.53%
Revenue Next 5YN/A
EBIT growth 1Y142.36%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year517.35%
EBIT Next 3Y93.94%
EBIT Next 5YN/A
FCF growth 1Y-102.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2%
OCF growth 3YN/A
OCF growth 5Y-5.14%